{"id":"tp-55652","type":"article-newspaper","title":"Century Therapeutics Posts $0.11 Q3 Loss Per Share as Net Loss Narrows","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/55652","datePublished":"2026-11-12T16:48:25.000Z","dateModified":"2026-11-12T16:48:25.000Z","language":"en","abstract":"The company had $174.1 million in cash, cash equivalents and investments at quarter-end and estimated the balance would support operations into the first quarter of 2029.","section":"Business","references":[]}